Transcriptional profiling clarifies a program of enzalutamide extreme non-response in lethal prostate cancer.
转录组分析揭示了致命性前列腺癌中恩扎卢胺极度无反应的机制
期刊:npj Precision Oncology
影响因子:8
doi:10.1038/s41698-025-01002-8
Kumaraswamy Anbarasu, Hu Ya-Mei, Yates Joel A, Zhang Chao, Rodansky Eva, Khokhani Dhruv, Flores Diana, Duan Zhi, Zhang Yi, Tabatabaei Shaadi, Slottke Rachel, Ye Shangyuan, Lara Primo, Foye Adam, Ryan Charles J, Quigley David A, Huang Jiaoti, Aggarwal Rahul, Reiter Robert E, Wicha Max S, Beer Tomasz M, Rettig Matthew, Gleave Martin, Evans Christopher P, Witte Owen N, Stuart Joshua M, Thomas George V, Feng Felix Y, Small Eric J, Xia Zheng, Alumkal Joshi J